Pharma Trials And Pediatric FDA Approval Will Open Global Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
11 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
UK£0.08
88.5% undervalued intrinsic discount15 Aug
UK£0.0092
1Y
-41.3%7D
-2.6%